Of therapeutic importance, IRAK 1/4 inhibition and/or RNA interference (RNAi) suppression of IRAK1 was selectively cytotoxic to MDS HSPCs without consequence to normal CD34+ cells (18). The gene discussed is CD34; the disease is myelodysplastic syndrome.